Prevalence of long-term mechanical insufflation-exsufflation in children with neurological conditions: a population-based study.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
05 2021
Historique:
accepted: 25 11 2020
pubmed: 5 1 2021
medline: 22 9 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

To determine the prevalence of long-term mechanical insufflation-exsufflation (MI-E) and concomitant mechanical ventilation in children with neurological conditions, with reported reasons behind the initiation of treatment. This was a population-based, cross-sectional study using Norwegian national registries and a questionnaire. In total, 114 of 19 264 children with a neurological condition had an MI-E device. Seventy-three of 103 eligible children (31 females, 42 males), median (min-max) age of 10 years 1 month (1y 5mo-17y 10mo), reported their MI-E treatment initiation. Overall, 76% reported airway clearance as the main reason to start long-term MI-E. A prophylactic use was mainly reported by children with neuromuscular disorders (NMDs). Prevalence and age at initiation differed by diagnosis. In spinal muscular atrophy and muscular dystrophies, MI-E use was reported in 34% and 7% of children, of whom 83% and 57% respectively received ventilator support. One-third of the MI-E users were children with central nervous system (CNS) conditions, such as cerebral palsy and degenerative disorders, and ventilator support was provided in 31%. The overall use of concomitant ventilatory support among the long-term MI-E users was 56%. The prevalence of MI-E in a neuropaediatric population was 6 per 1000, with two-thirds having NMDs and one-third having conditions of the CNS. The decision to initiate MI-E in children with neurological conditions relies on clinical judgment. The prevalence and age at initiation of mechanical insufflation/exsufflation (MI-E) differed between diagnoses. MI-E was most commonly used in spinal muscular atrophy, where it generally coincided with ventilatory support. One-third of MI-E devices were given to children with central nervous system conditions, and one-third also received ventilatory support.

Identifiants

pubmed: 33393110
doi: 10.1111/dmcn.14797
pmc: PMC8048789
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

537-544

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.

Références

Chest. 2000 Nov;118(5):1390-6
pubmed: 11083691
Respir Care. 2020 Feb;65(2):135-143
pubmed: 31690614
Pediatr Pulmonol. 2015 Oct;50(10):1033-8
pubmed: 25327770
J Child Neurol. 2014 May;29(5):646-53
pubmed: 24022110
Thorax. 2012 Jul;67 Suppl 1:i1-40
pubmed: 22730428
Pediatr Pulmonol. 2020 Feb;55(2):510-513
pubmed: 31909568
Dev Med Child Neurol. 2021 Jan;63(1):75-80
pubmed: 32314347
Paediatr Respir Rev. 2009 Mar;10(1):18-24
pubmed: 19203740
Neuromuscul Disord. 2018 Mar;28(3):289-298
pubmed: 29395673
Eur Respir J. 2003 Mar;21(3):502-8
pubmed: 12662009
Arch Dis Child. 2011 May;96(5):426-32
pubmed: 20573738
J Phys Ther Sci. 2014 Mar;26(3):389-91
pubmed: 24707090
Respir Care. 2018 Feb;63(2):187-193
pubmed: 29066586
Dev Med Child Neurol. 2019 Jun;61(6):646-653
pubmed: 30320434
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Respir Care. 2018 Dec;63(12):1506-1513
pubmed: 30206128
Child Care Health Dev. 2019 Sep;45(5):754-771
pubmed: 31276598
Respir Med. 2018 Mar;136:98-110
pubmed: 29501255
Pediatr Pulmonol. 2018 Oct;53(10):1378-1386
pubmed: 30129703
Paediatr Respir Rev. 2018 Jun;27:69-73
pubmed: 29239774

Auteurs

Brit Hov (B)

Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Tiina Andersen (T)

Norwegian Advisory Unit on Long-term Mechanical Ventilation, Thoracic Department, Haukeland University Hospital, Bergen, Norway.
Physiotherapy Department, Haukeland University Hospital, Bergen, Norway.

Michel Toussaint (M)

Centre for Neuromuscular Disorders and Home Mechanical Ventilation, UZ Brussel-Inkendaal, Vlezenbeek, Belgium.

Maria Vollsaeter (M)

Norwegian Advisory Unit on Long-term Mechanical Ventilation, Thoracic Department, Haukeland University Hospital, Bergen, Norway.
Department of Paediatrics, Haukeland University Hospitals, Bergen, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.

Ingvild B Mikalsen (IB)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Paediatric Medicine, Stavanger University Hospital HF, Stavanger, Norway.

Solfrid Indrekvam (S)

Norwegian Advisory Unit on Long-term Mechanical Ventilation, Thoracic Department, Haukeland University Hospital, Bergen, Norway.

Vegard Hovland (V)

Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH